Background-Mitral regurgitation (MR) is associated with reduced survival in patients with chronic heart failure, but may be improved with cardiac resynchronization therapy (CRT). We sought to evaluate the relationship between serial measurements of functional MR and reverse remodeling and outcomes in patients undergoing CRT.
F unctional mitral regurgitation (MR) is widely accepted as a strong predictor of outcome in patients with systolic heart failure. [1] [2] [3] [4] [5] The presence of MR in chronic left ventricular (LV) dysfunction reflects an imbalance between closing forces acting on the mitral leaflets and tethering forces related to papillary muscle displacement. [6] [7] [8] Previous studies have shown that cardiac resynchronization therapy (CRT) may improve the degree of MR, both immediately (by resynchronization of the papillary muscles and by causing a short-term increase in LV closing force) and in the longer-term as a consequence of reverse remodeling (resulting in a reduction of mitral valve tethering forces). 9 -13 
Clinical Perspective on p 26
Patients with significant MR and advanced LV dysfunction, especially those with wide QRS morphological features, pose a particularly difficult management dilemma because the benefits of surgical repair for correction of the MR in this population have been equivocal. 14 With the advent of CRT and its antici-pated benefits on functional MR via correction of the underlying ventricular dyssynchrony, it would seem appropriate that CRT should be considered as first-line therapy, with surgical repair reserved for those not responding to CRT.
We, therefore, sought to examine the importance of both preexisting MR and early and late changes in MR severity on long-term reverse remodeling with CRT and hypothesized that significant reductions in MR, leading to reverse remodeling, can be detected early after CRT implantation, thereby providing guidance for further management.
Methods
The study protocol was approved by the Cleveland Clinic Institutional Review Board.
Study Population and Study Design
We assessed patients who underwent first CRT device implantation at the Cleveland Clinic between January 2003 and June 2006 and who had a minimal echocardiographic follow-up of 90 days. 15 Patients with a major event during these first 3 months (early death or urgent trans-plantation) were excluded. Baseline and every subsequent echocardiogram obtained at our institution during the follow-up of the patient after initiation CRT were systematically reviewed and measured by 2 experienced readers (D.V. and Z.B.P.). Because our goal was to assess functional MR (ie, regurgitation occurring as a consequence of LV systolic dysfunction, despite a structurally normal mitral valve), we excluded from the original population the patients with significant organic (structural) mitral valve disease or history of mitral valve repair or replacement.
Demographic and clinical data were extracted from medical records. The cause of heart failure was considered ischemic on the basis of a documented clinical history of myocardial infarction (with ECG evidence of infarct location) or a history of revascularization. The events were ascertained using the Social Security Death Index and reviewing patients' electronic case records.
Echocardiographic Analysis
All echocardiographic studies were digitally stored and measured off-line using Prosolv Cardiovascular software (Fuji Inc; Tokyo, Japan). Early post-CRT studies were defined as studies performed within the first 6 days after CRT implantation, with the date of implantation being time 0. Conventional 2-and 4-chamber images were used to calculate LV end-diastolic volume, LV end-systolic volume (LVESV), and LV ejection fraction using the Simpson biplane method. 16 All volumes were indexed according to body surface area. Left atrial size was assessed by left atrial area. The severity of MR was quantitated by vena contracta (VC; ie, width of the neck or narrowest portion of the regurgitant jet). [17] [18] [19] In addition, we calculated the ratio of the jet area/left atrial area 20, 21 and the effective regurgitant orifice area (ERO). 7, 22 For VC and ERO measurements, if 2 jets were present, the dominant was taken as representative. Each of these 3 quantitative measurements was then transformed into a semiquantitative 5-point grading scale (0 -4) using the following respective cutoff values: 0, Ͻ10%, 10% to 20%, 20% to 45%, and Ͼ45% for jet area/LA area; 0, Ͻ3 mm, 3 to 5 mm, 5 to 7, mm, and Ͼ7 mm for VC; and 0, Ͻ0.15 cm 2 , 0.15 to 0.29 cm 2 , 0.30 to 0.40 cm 2 , and Ͼ0.40 cm 2 for ERO. The value of 3 individual grades was then combined into a single MR grade (by calculating their median, determined using MS Excel software, Microsoft Corp; Seattle, WA), which was then used in survival analysis.
To assess interobserver and intraobserver variability of VC measurements, we analyzed 12 studies obtained in 6 patients, with each patient contributing 2 studies, 1 of them being pre-CRT. From each study, we selected the representative multiple-beat clip showing VC. Studies were measured by 2 independent observers (D.V. and Z.B.P.) and a single observer after an interval of 1 month. For each study, maximum VC was measured in midsystole in 2 consecutive beats during separate sessions for each of the 2 beats. To assess the observer variability while including the impact of beat-to-beat variability, we calculated the absolute difference in VC measurement obtained during the first of the 2 consecutive beats by the first observer with VC measurement obtained during the second beat by a second observer. An analogous process was used for intraobserver variability. To assess the observer variability after excluding the impact of beat-to-beat variability, we calculated the absolute difference in VC measurement obtained during measurement of the first beat by 2 observers. An analogous process was used for intraobserver variability. Finally, to assess the interobserver and intraobserver variability in the assessment of change in MR severity, we first calculated the difference in VC, measured during a first beat of the clip, between 2 studies obtained in a single patient. Interobserver and intraobserver variabilities were calculated as previously described.
Statistical Analysis
Data are presented as the meanϮSD, unless otherwise noted.
To assess the evolution of MR severity (assessed by VC) and LV end-systolic volume index (LVESVi) during CRT, we applied a linear mixed-effects model with unstructured covariance for random effects using SPSS (SPSS Inc; Chicago, IL). 23 In a first step, we assessed the impact of CRT on MR. Previous studies have shown that CRT leads to both immediate and late decrease of MR. 24 To model the effects of CRT, we used a piecewise linear regression for both fixed and random effects. We tested the models with the break point set up at the 3rd, 90th, 180th, and 360th day of CRT. 15, 23 In a second step, we assessed the timed-dependent correlation between changes in MR and the amount of reverse remodeling during CRT. For this purpose, we again used a linear mixed-effects model approach to correlate VC change from baseline with percentage LVESVi change from baseline, with the time covariate set to 0 if the data were assessed during the first 7 days and to 1 if otherwise.
In a third step, we assessed if pre-CRT MR severity affects LV remodeling and left atrial remodeling during CRT. LVESVi and left atrial area were used as markers of LV and left atrial remodeling, respectively. According to pre-CRT MR, patients were divided into a group with severe MR (MR grade Ͼ2) and a group with no more than moderate MR (MR grade Յ2). We again used piecewise linear regression with the break point set up at the 90th, 180th, and 360th day of CRT. 15, 23 For all linear mixed effects, the Akaike information criterion was used to compare the incremental value of models. Wald statistics was used to test for the difference in slopes of piecewise regression. 23 Additional data are provided in the Online Only Data Supplement. To assess the prognostic value of baseline MR severity and MR severity during follow-up, we compared survival curves constructed by Kaplan-Meier by log-rank statistics, with the end point being a composite of death from any cause (determined by the Social Security Death Index), heart transplantation, or LV assist device implantation. We also performed a stepwise Cox proportional hazards regression with the combined end point of all-cause death, heart transplantation, or LV assist device implantation. Variables entered as potential predictors included age, sex, New York Heart Association class, QRS duration, heart failure cause, lead position, MR severity, and baseline LVESVi.
In all analyses, PϽ0.05 was significant.
Results

Patients
We identified 1067 patients with a first CRT device implanted at the Cleveland Clinic between January 2003 and June 2006. Of these patients, 754 were excluded because no echocardiogram was available after Ͼ90 days of CRT (nϭ721) or a clinical event occurred within the first 90 days (nϭ33). Of the remaining 313 patients, 44 had prior mitral valve surgery, 2 did not have adequate echocardiograms for MR assessment, and 1 had mitral valve repair after the start of resynchronization therapy (Online Only Data Supplement Figure 1 ), leaving 266 patients to be analyzed. None of these patients had structural mitral valve disease. In 155 (58%) of the subjects, echocardiography within the first 6 days (2.2Ϯ3.3 days) after CRT implantation was performed. A total of 113 patients experienced Ͼ15% reduction in LVESVi (82 had a 0%-15% reduction in LVESVi); 71 patients had an increase in LVESVi, despite CRT. The baseline characteristics of our study population are described in the 
Changes in MR Severity During CRT
MR severity assessed by VC promptly decreased with CRT. The best model for describing temporal change of MR severity during CRT was a piecewise regression with a break point at day 3 ( Figure  1) , with a significant early decrease in MR (VC decrease, 0.8 mm; PՅ0.0001), and no significant change during follow-up. Figure 2 shows the relationship between VC change and percentage LVESVi change early (during the first 7 days, Figure 2A ) and late (after Ͼ7 days, Figure 2B ) after the start of CRT. Early after the start of CRT, there was no correlation between VC change and percentage ESVi change (Pϭ0.14), with most patients experiencing a VC decrease without a significant LVESVi change. In contrast, during late followup, there was a significant correlation between these 2 parameters (PϽ0.0001), with a significant decrease in both percentage LVESVi and VC. In summary, early MR improvement was followed by LV reverse remodeling. Figure 3 shows the impact of baseline (pre-CRT) MR severity on LV remodeling. As previously shown, 15 the best model for describing temporal change of LVESVi during CRT was a piecewise regression with a break point at 3 months. Although LVESVi decreased in both groups (PϽ0.0001), reverse remodeling during the initial 3 months was more pronounced in patients with more severe baseline MR (Pϭ0.005). Interestingly, although there was a trend toward higher left atrial areas in patients with more severe baseline MR (28.5Ϯ5.9 versus 26.7Ϯ6.7 cm 2 ; Pϭ0.09), no changes within or between groups were observed during follow-up. (Figure 4 ). In the next step, we analyzed if survival is related to either decrease in MR grade or MR grade during CRT. For this purpose, we determined the minimal MR grade observed at any time during the first 6 months of treatment. During this period, 5 patients died, whereas 37 patients did not have an adequate echocardiogram performed during the first 6 months they were excluded from the analysis, leaving the final group of 224 patients. Both the decrease in MR grade (Pϭ0.001; HR, 0.64; 95% CI, 0.50 -0.83) and MR grade during CRT (Pϭ0.03; HR, 1.27; 95% CI, 1.02-1.58) were independent predictors in a multivariable stepwise Cox model that included relevant clinical variables. Figure 5 shows that patients with an MR grade of 2ϩ or less during the first 6 months of CRT had significantly better survival.
Impact of Pre-CRT MR on LV and Left Atrial Remodeling
Impact of MR Severity on Outcome in Patients Undergoing CRT
Intraobserver and Interobserver Variability
Intraobserver and interobserver variabilities for the measurement of VC, while including the impact of beat-to-beat variability, were 1.6Ϯ1.3 and 1.7Ϯ1.2 mm, respectively. Intraobserver and interobserver variabilities for the measurement of VC, while excluding the impact of beat-to-beat variability, were 1.0Ϯ0.8 and 1.1Ϯ1.0 mm, respectively. Intraobserver and interobserver variabilities for the measurement of change in VC were 2.0Ϯ1.4 and 2.1Ϯ1.7 mm, respectively.
Discussion
The novel findings of our study are that most of the decrease in MR during CRT occurs within days of initiation of biventricular pacing. In fact, we have not shown any further significant MR decrease during follow-up. Furthermore, we have shown that, although early after starting CRT, there is no correlation between MR decrease and LVESVi decrease, this correlation becomes apparent at later follow-up, implying the role of early MR in reverse LV remodeling. Finally, patients with significant (Ͼ2ϩ) MR pre-CRT experienced more reverse remodeling, indicating that severe functional MR does not interfere with the effects of CRT.
Because an early MR decrease precedes subsequent LV remodeling (Figures 1-3 ), it appears that there is both a statistical and a biological interaction between amount of LV remodeling and MR during CRT, during which an immediate MR decrease heralds subsequent reverse remodeling. An average decrease of close to 2 mm in VC, which was observed in patients with the most remodeling, is clinically relevant and can be detected in individual patients.
Immediate Versus Late Effects of CRT on MR Severity
Although CRT decreases both MR and LV volumes, an immediate decrease of MR occurs before any significant LV remodeling. 24, 25 Possible mechanisms include an increase in the rate of LV pressure increase, which counteracts tethering forces and leads to more effective mitral valve closure 9 and improved papillary muscle dyssynchrony. 10, 12 This immediate change in MR could be expected to have some prognostic significance. Surprisingly, the analysis of Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study data did not show a correlation between immediate MR decrease and subsequent LV remodeling. Possible reasons are inclusion of patients with no or mild symptoms, MR presence in a few patients, and method used for MR quantitation. 25 In contrast, our findings show the link between MR decrease and LV remodeling. Although an MR decrease preceded LV remodeling, there was a clear correlation between late changes in MR and LVESVi, with a larger MR decrease leading to a larger LVESVi decrease. Assuming that an early MR decrease is stable during late follow-up, which is supported by our data, this temporal sequence suggests that an early MR decrease may play a role in reverse remodeling of the left ventricle.
Reverse LV Remodeling, Survival, and the Impact of MR Before and Immediately After the Start of CRT Although functional MR in patients with heart failure conveys an adverse prognosis, [1] [2] [3] [4] our study implies that severe preimplantation MR may not necessarily predict worse outcome in patients with heart failure undergoing CRT. Indeed, patients with pronounced baseline MR in our series experienced more reverse remodeling. Our analysis did not account for other factors that may influence remodeling, and analysis of echocardiographic data from the Cardiac Resynchronization in Heart Failure trial showed that baseline MR is not a predictor of remodeling in a multivariate analysis. 26 However, these findings, in addition to our findings of the absence of the impact of baseline MR on survival, indicate that CRT can be safely implemented, even in the setting of severe functional MR.
In contrast, the presence of Ͼ2ϩ MR after the initial 6 months of CRT was predictive of adverse events, which is consistent with Cardiac Resynchronization in Heart Failure data. 22 The decrease of MR during CRT can be interpreted as a surrogate index of both LV remodeling and resynchronization. Interestingly, the relative contribution of LV reverse remodeling and resynchronization to survival benefit brought by CRT is controversial. For example, Ypenburg et al showed that prognosis after CRT is related to the extent of LV reverse remodeling, 27 whereas the Cardiac Resynchronization in Heart Failure substudy showed that survival benefit from CRT was not significantly different between nonischemic (HR, 0.46) and ischemic (HR, 0.71) patients (Pϭ0.06), despite nonischemic patients having much more reverse remodeling. 28 On the other hand, the study may have been underpowered, because a difference in HRs of 0.25 is not clinically irrelevant; further studies will be necessary to answer this question.
Strengths and Limitations
The major strengths of this study are a large sample size, digital data analysis, MR quantitation by VC, and a longitudinal approach to data evaluation that enabled us to construct the shape of the average trajectory of the change in LVESVi and MR severity during CRT. Although several prospective randomized CRT trials that serially assessed MR are superior to our study by the number of patients and the prospective nature of the design, they invariably used ratio between regurgitant jet and left atrial area as a marker of MR severity, which is known to be affected by multiple technical issues, and were often performed off of videotapes, which have Ͼ2 times lower linear resolution than digital data. 25, 26, 29 Our major limitations are that our study was retrospective and observational, with a population composed of patients with clinical and echocardiographic follow-up in a tertiary care center, and a selection bias cannot be excluded. Patients with a major adverse event within the first 90 days of implantation were not included in this study, because we were particularly interested in the effects of MR on long-term reverse remodeling. These patients may be early nonresponders, and the role of MR in the lack of response to CRT in this group remains speculative. Only a proportion of patients underwent echocardiography in the first few days after implantation, which may have influenced our observation on the early effect of CRT on MR.
Information on the development of atrial fibrillation and the proportion of effective biventricular pacing in our study population was not available, although this may have represented another potentially important mediator of response and outcome. We used left atrial area as a measure of its size instead of indexed left atrial volumes, which is a less precise method. We have not quantitated the number of MR jets or whether the presence of multiple jets is a predictor of the outcome of CRT. However, all of our patients had functional MR, which should decrease the variability of MR characteristics.
Finally, this was an observational study implying that changes in pharmacological or nonpharmacological therapies during follow-up may have influenced MR severity, outcome, and remodeling. However, to include these effects in the statistical model would have made the analysis more complex. In addition, we believe that the observational nature of the study makes the results representative of real-life clinical practice.
Clinical Implications
MR is widely prevalent among patients with dilated ischemic or nonischemic cardiomyopathy and is generally associated with poor outcome. Because long-term survival in this population does not appear to be improved by mitral valve annuloplasty 14 alone, CRT may offer a valid alternative in the absence of organic mitral valve lesions. The ability to detect reductions in MR severity within the first week of CRT implantation provides an early insight into the potential clinical response to CRT. Furthermore, it provides another functional parameter to target for optimization of pacing intervals and configurations.
Conclusions
Early reduction of MR appears to be associated with a greater potential decrease in LVESVI. Furthermore, the presence of significant MR in patients who are otherwise candidates does not preclude CRT response. Finally, the presence of greater than moderate MR after the 6-month mark portends an adverse long-term outcome. 
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